Mega Lifesciences PCL
SET:MEGA

Watchlist Manager

Mega Lifesciences PCL

SET:MEGA

Watchlist

Dividends

Discount Rate

Price: 35.25 THB -0.7% Market Closed

Market Cap: 30.7B THB

Have any thoughts about
Mega Lifesciences PCL?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 35.25 THB

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MEGA Alert

Mega Lifesciences PCL

35.25

-0.25 (-0.7%)

52 Week Range	35.25 44
Price Target

We'll email you a reminder when the closing price reaches THB.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Mega Lifesciences PCL

What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?

What risks and challenges
does Mega Lifesciences PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Mega Lifesciences PCL.

What unique competitive advantages
does Mega Lifesciences PCL hold over its rivals?

What risks and challenges
does Mega Lifesciences PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mega Lifesciences PCL.

Provide P/S
for Mega Lifesciences PCL.

Provide P/E
for Mega Lifesciences PCL.

Provide P/OCF
for Mega Lifesciences PCL.

Provide P/FCFE
for Mega Lifesciences PCL.

Provide P/B
for Mega Lifesciences PCL.

Provide EV/S
for Mega Lifesciences PCL.

Provide EV/GP
for Mega Lifesciences PCL.

Provide EV/EBITDA
for Mega Lifesciences PCL.

Provide EV/EBIT
for Mega Lifesciences PCL.

Provide EV/OCF
for Mega Lifesciences PCL.

Provide EV/FCFF
for Mega Lifesciences PCL.

Provide EV/IC
for Mega Lifesciences PCL.

Show me price targets
for Mega Lifesciences PCL made by professional analysts.

What are the Revenue projections
for Mega Lifesciences PCL?

How accurate were the past Revenue estimates
for Mega Lifesciences PCL?

What are the Net Income projections
for Mega Lifesciences PCL?

How accurate were the past Net Income estimates
for Mega Lifesciences PCL?

What are the EPS projections
for Mega Lifesciences PCL?

How accurate were the past EPS estimates
for Mega Lifesciences PCL?

What are the EBIT projections
for Mega Lifesciences PCL?

How accurate were the past EBIT estimates
for Mega Lifesciences PCL?

Compare the revenue forecasts
for Mega Lifesciences PCL with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mega Lifesciences PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mega Lifesciences PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mega Lifesciences PCL compared to its peers.

Compare the P/E ratios
of Mega Lifesciences PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing Mega Lifesciences PCL with its peers.

Analyze the financial leverage
of Mega Lifesciences PCL compared to its main competitors.

Show all profitability ratios
for Mega Lifesciences PCL.

Provide ROE
for Mega Lifesciences PCL.

Provide ROA
for Mega Lifesciences PCL.

Provide ROIC
for Mega Lifesciences PCL.

Provide ROCE
for Mega Lifesciences PCL.

Provide Gross Margin
for Mega Lifesciences PCL.

Provide Operating Margin
for Mega Lifesciences PCL.

Provide Net Margin
for Mega Lifesciences PCL.

Provide FCF Margin
for Mega Lifesciences PCL.

Show all solvency ratios
for Mega Lifesciences PCL.

Provide D/E Ratio
for Mega Lifesciences PCL.

Provide D/A Ratio
for Mega Lifesciences PCL.

Provide Interest Coverage Ratio
for Mega Lifesciences PCL.

Provide Altman Z-Score Ratio
for Mega Lifesciences PCL.

Provide Quick Ratio
for Mega Lifesciences PCL.

Provide Current Ratio
for Mega Lifesciences PCL.

Provide Cash Ratio
for Mega Lifesciences PCL.

What is the historical Revenue growth
over the last 5 years for Mega Lifesciences PCL?

What is the historical Net Income growth
over the last 5 years for Mega Lifesciences PCL?

What is the current Free Cash Flow
of Mega Lifesciences PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mega Lifesciences PCL.

MEGA

Balance Sheet

Accounts Payable

Mega Lifesciences PCL
Accounts Payable

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Mega Lifesciences PCL
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company		Accounts Payable	CAGR 3Y	CAGR 5Y	CAGR 10Y
M	Mega Lifesciences PCL SET:MEGA	Accounts Payable ฿1.8B	CAGR 3-Years -12%	CAGR 5-Years 0%	CAGR 10-Years 4%
B	Bangkok Lab and Cosmetic PCL SET:BLC	Accounts Payable ฿96.5m	CAGR 3-Years -8%	CAGR 5-Years 2%	CAGR 10-Years N/A

No Stocks Found

Mega Lifesciences PCL
Glance View

Market Cap

30.7B THB

Industry

Pharmaceuticals

Mega Lifesciences Public Co. Ltd. engages in the manufacture, market, sale, and distribution of pharmaceutical, nutraceutical products, and consumer goods. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2013-11-19. The firm's products include complimentary medicines, over-the-counter (OTC) medicines and prescription medicines to both domestic and international markets. The company distributes products under Maxxcare brand covering prescription pharmaceutical products, OTC drugs and other consumer products. The firm also offers nutritional products, prescription pharmaceutical products and OTC drugs under Mega We Care brand. In addition, the Company operates as an original equipment manufacturer (OEM) for various products including health supplements, pharmaceutical, herbal products, vitamins and minerals, among others.

Open MEGA Analysis

MEGA Intrinsic Value

53.62 THB

Undervaluation 34%

Intrinsic Value

Price

What is Intrinsic Value?

What is Mega Lifesciences PCL's Accounts Payable?

Accounts Payable
1.8B THB

Based on the financial report for Sep 30, 2024, Mega Lifesciences PCL's Accounts Payable amounts to 1.8B THB.

What is Mega Lifesciences PCL's Accounts Payable growth rate?

Accounts Payable CAGR 10Y
4%

Over the last year, the Accounts Payable growth was -27%. The average annual Accounts Payable growth rates for Mega Lifesciences PCL have been -12% over the past three years , and 4% over the past ten years .

Mega Lifesciences PCL
SET:MEGA

Mega Lifesciences PCL
Accounts Payable

Mega Lifesciences PCL
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Mega Lifesciences PCL
Glance View

See Also

What is Mega Lifesciences PCL's Accounts Payable?

Accounts Payable
1.8B THB

What is Mega Lifesciences PCL's Accounts Payable growth rate?

Accounts Payable CAGR 10Y
4%

Company

Help

Tools

Stocks

Mega Lifesciences PCL SET:MEGA

Mega Lifesciences PCL Accounts Payable

Mega Lifesciences PCL Accounts Payable Peer Comparison

Competitors Analysis Latest Figures & CAGR of Competitors

Mega Lifesciences PCL Glance View

See Also

What is Mega Lifesciences PCL's Accounts Payable? Accounts Payable 1.8B THB

What is Mega Lifesciences PCL's Accounts Payable growth rate? Accounts Payable CAGR 10Y 4%

Company

Help

Tools

Stocks

Mega Lifesciences PCL
SET:MEGA

Mega Lifesciences PCL
Accounts Payable

Mega Lifesciences PCL
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Mega Lifesciences PCL
Glance View

What is Mega Lifesciences PCL's Accounts Payable?

Accounts Payable
1.8B THB

What is Mega Lifesciences PCL's Accounts Payable growth rate?

Accounts Payable CAGR 10Y
4%